Related references
Note: Only part of the references are listed.The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study
Aikaterini Giannouli et al.
JOURNAL OF CLINICAL MEDICINE (2023)
The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome
Dong Liu et al.
BMC MEDICINE (2023)
The role of hepatokines in NAFLD
Norbert Stefan et al.
CELL METABOLISM (2023)
Elevated circulating Selenoprotein P levels in patients with polycystic ovary syndrome
Muzaffer Temur et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome
Claire Falzarano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis
Xiaofang Zhang et al.
GENES (2022)
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Myeong Jun Song et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
Ruirui Yu et al.
ANTIOXIDANTS (2022)
Sex hormone-binding globulin: biomarker and hepatokine?
Pomme I. H. G. Simons et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
Feifei Cheng et al.
ENDOCRINE CONNECTIONS (2021)
Selenium and selenoprotein P in nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2020)
Using human genetics to understand the disease impacts of testosterone in men and women
Katherine S. Ruth et al.
NATURE MEDICINE (2020)
Cutoff values for HOMA-IR associated with metabolic syndrome in the Study of Cardiovascular Risk in Adolescents (ERICA Study)
Rafaelle de Barros Caxiano Chissini et al.
NUTRITION (2020)
Selenium and selenoproteins: it's role in regulation of inflammation
Sneha Hariharan et al.
INFLAMMOPHARMACOLOGY (2020)
Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome
Sha Liu et al.
BMC ENDOCRINE DISORDERS (2020)
FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation
Helle Keinicke et al.
ENDOCRINE CONNECTIONS (2020)
Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome
Sylwia Bednarska et al.
CYTOKINE (2020)
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis
Matthew Dapas et al.
PLOS MEDICINE (2020)
Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women
Manjunath Ramanjaneya et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Stavroula A. Paschou et al.
ENDOCRINE (2020)
FGF19 subfamily members: FGF19 and FGF21
Katarzyna Dolegowska et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index)
Anne-Marie Carreau et al.
CLINICAL ENDOCRINOLOGY (2019)
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Marta Flisiak-Jackiewicz et al.
ADVANCES IN MEDICAL SCIENCES (2019)
Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex
M. Angeles Martinez-Garcia et al.
NUTRIENTS (2019)
Role of hepatokines in non-alcoholic fatty liver disease
Yini Ke et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2019)
Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome
S. Kahraman et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome
Sibel Sak et al.
CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM (2018)
An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
Lourdes Ibanez et al.
HORMONE RESEARCH IN PAEDIATRICS (2017)
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)
Miriam B. Vos et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Selenium status parameters in patients with polycystic ovary syndrome
P. Zagrodzki et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2017)
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
Ruth C. R. Meex et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Hepatokines and non-alcoholic fatty liver disease
Dariusz M. Lebensztejn et al.
ACTA BIOCHIMICA POLONICA (2016)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys
Oyekoya T. Ayonrinde et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance
Melanie Cree-Green et al.
OBESITY (2016)
Transient Elastography-Based Liver Stiffness Age-Dependently Increases in Children
Daisuke Tokuhara et al.
PLOS ONE (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2
Neil F. Goodman et al.
ENDOCRINE PRACTICE (2015)
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Selma F. Witchel et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome
Magdalena Olszanecka-Glinianowicz et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Fetuin-A levels in lean and obese women with polycystic ovary syndrome
Jaroslaw Kozakowski et al.
ENDOKRYNOLOGIA POLSKA (2014)
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
Didier Dewailly et al.
HUMAN REPRODUCTION UPDATE (2014)
Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children
B-J Ko et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
Annika Mutanen et al.
JOURNAL OF HEPATOLOGY (2014)
Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome
Serap B. Sahin et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2014)
The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome
Remzi Abali et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile
Sara F. Michaliszyn et al.
FERTILITY AND STERILITY (2013)
Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome
Yasar Enli et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2013)
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans
Norbert Stefan et al.
NATURE MEDICINE (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
Anna Alisi et al.
PLOS ONE (2013)
Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease
Hae Yoon Choi et al.
DIABETES & METABOLISM JOURNAL (2013)
Serum Fetuin-A levels in women with polycystic ovary syndrome
Ibrahim Gulhan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2012)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
John Willy Haukeland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
Thomas Reinehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Fetuin-A: A Multifunctional Protein
Katsuhito Mori et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2011)
PCOS in adolescents
Evanthia Diamanti-Kandarakis
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2010)
A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance
Hirofumi Misu et al.
CELL METABOLISM (2010)
Relationships of Circulating Sex Hormone-Binding Globulin With Metabolic Traits in Humans
Andreas Peter et al.
DIABETES (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
Suheyla Gorar et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice
Kostja Renko et al.
FASEB JOURNAL (2009)
The Prevalence of Abnormal Liver Enzymes and Metabolic Syndrome in Obese Adolescent Females with Polycystic Ovary Syndrome
Elaine Barfield et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2009)
Bounding sample size projections for the area under a ROC curve
Jeffrey D. Blume
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2009)
Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men.
Eric L. Ding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor
Philippe L. Walter et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
Thomas Reinehr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
Sample size of 12 per group rule of thumb for a pilot study
SA Julious
PHARMACEUTICAL STATISTICS (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor
ST Mathews et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
